PETRA-03

N/A

Report date: 2025/01/26 17:38:03
NME

Base Information

Drug NamePETRA-03
Drug Alias NameMutant Phosphoinositide-3 Kinase Alpha Inhibitor (Takeda)Mutant Phosphoinositide-3 Kinase Alpha Inhibitor (Petra)PETRA-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPetra Pharma Corp
Inactive CompaniesMillennium Pharmaceuticals Inc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A